An effective immunization and cancer treatment with activated dendritic cells transduced with full-length wild-type p53.
- Published in:
- Gene Therapy, 2002, v. 9, n. 5, p. 345, doi. 10.1038/sj.gt.3301670
- By:
- Publication type:
- Article
Works matching IS 09697128 AND DT 2002 AND VI 9 AND IP 5
Results: 7
1
2
Transient suppression of transgene expression by means of antisense oligonucleotides: a method for the production of toxin-transducing recombinant viruses.
- Published in:
- Gene Therapy, 2002, v. 9, n. 5, p. 358, doi. 10.1038/sj.gt.3301660
- By:
- Publication type:
- Article
3
Growth inhibition of established B16-F10 lung metastases by sequential aerosol delivery of p53 gene and 9-nitrocamptothecin.
- Published in:
- Gene Therapy, 2002, v. 9, n. 5, p. 353, doi. 10.1038/sj.gt.3301662
- By:
- Publication type:
- Article
4
Improved co-expression of multiple genes in vectors containing internal ribosome entry sites (IRESes) from human genes.
- Published in:
- Gene Therapy, 2002, v. 9, n. 5, p. 337, doi. 10.1038/sj.gt.3301667
- By:
- Publication type:
- Article
5
LCR-mediated, tong-term tissue-specific gene expression within replicating episomal plasmid and cosmid vectors.
- Published in:
- Gene Therapy, 2002, v. 9, n. 5, p. 327, doi. 10.1038/sj.gt.3301654
- By:
- Publication type:
- Article
6
Inhibition of retinal neovascularisation by gene transfer of soluble VEGF receptor sFlt-1.
- Published in:
- Gene Therapy, 2002, v. 9, n. 5, p. 320, doi. 10.1038/sj.gt.3301680
- By:
- Publication type:
- Article
7
Intrabody-mediated phenotypic knockout of major histocompatibility complex class I expression in human and monkey cell lines and in primary human keratinocytes.
- Published in:
- Gene Therapy, 2002, v. 9, n. 5, p. 307, doi. 10.1038/sj.gt.3301656
- By:
- Publication type:
- Article